Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography
- PMID: 20224372
- DOI: 10.1097/SLA.0b013e3181d3599c
Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography
Abstract
Progressive postinjury coagulopathy remains the fundamental rationale for damage control surgery, but the decision to abort operative intervention must occur before laboratory confirmation of coagulopathy. Current massive transfusion protocols have embraced pre-emptive resuscitation strategies emphasizing administration of packed red blood cells, fresh frozen plasma, and platelets in ratios approximating 1:1:1 during the first 24 hours postinjury, based on US military retrospective experience and recent noncontrolled civilian data. This policy, termed "damage control resuscitation" assumes that patients presenting with life threatening hemorrhage at risk for postinjury coagulopathy should receive component therapy in rations approximating those found in whole blood during the first 24 hours. While we concur with the concept of pre-emptive coagulation factor replacement, and initially suggested this in 1982, we remain concerned for the continued unbridled administration of fresh frozen plasma and platelets without objective evidence of their specific requirement. A major limitation of current massive transfusion protocols is the lack of real time assessment of coagulation function to guide evolving blood component requirements. Existing laboratory coagulation testing was originally designed for evaluation of hemophilia and subsequently used for monitoring anticoagulation therapy. Consequently, the applicability of these tests in the trauma setting has never been proven and the time required to conduct these assays is incompatible with prompt correction of the coagulopathy in the trauma setting. This review examines the current approach to postinjury coagulopathy, including identification of patients at risk, resuscitation strategies, design and implementation of institutional massive transfusion protocols, and the potential benefits of goal-directed therapy by real time assessment of coagulation function via point of care rapid thromboelastography.
Similar articles
-
Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.J Surg Res. 2009 Sep;156(1):133-8. doi: 10.1016/j.jss.2009.03.046. Epub 2009 May 3. J Surg Res. 2009. PMID: 19577246
-
The impact of early thromboelastography directed therapy in trauma resuscitation.Scand J Trauma Resusc Emerg Med. 2017 Oct 5;25(1):99. doi: 10.1186/s13049-017-0443-4. Scand J Trauma Resusc Emerg Med. 2017. PMID: 28982391 Free PMC article.
-
Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy.Transfusion. 2012 Jan;52(1):23-33. doi: 10.1111/j.1537-2995.2011.03264.x. Epub 2011 Jul 25. Transfusion. 2012. PMID: 21790635
-
Transfusion strategies in postinjury coagulopathy.Curr Opin Anaesthesiol. 2009 Apr;22(2):289-98. doi: 10.1097/ACO.0b013e32832678ed. Curr Opin Anaesthesiol. 2009. PMID: 19390256 Review.
-
Massive transfusion in the trauma patient: Continuing Professional Development.Can J Anaesth. 2012 Dec;59(12):1130-45. doi: 10.1007/s12630-012-9795-4. Epub 2012 Oct 18. Can J Anaesth. 2012. PMID: 23076727 Review. English, French.
Cited by
-
Clinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.Crit Care. 2011;15(6):242. doi: 10.1186/cc10498. Epub 2011 Dec 8. Crit Care. 2011. PMID: 22188866 Free PMC article. Review.
-
Thromboelastography After Murine TBI and Implications of Beta-Adrenergic Receptor Knockout.Neurocrit Care. 2016 Aug;25(1):145-52. doi: 10.1007/s12028-015-0223-9. Neurocrit Care. 2016. PMID: 26666545
-
Development and validation of a high throughput whole blood thrombolysis plate assay.Sci Rep. 2017 May 24;7(1):2346. doi: 10.1038/s41598-017-02498-2. Sci Rep. 2017. PMID: 28539608 Free PMC article.
-
The systemic immune response to trauma: an overview of pathophysiology and treatment.Lancet. 2014 Oct 18;384(9952):1455-65. doi: 10.1016/S0140-6736(14)60687-5. Epub 2014 Oct 17. Lancet. 2014. PMID: 25390327 Free PMC article. Review.
-
Discrepancies between conventional and viscoelastic assays in identifying trauma-induced coagulopathy.Am J Surg. 2019 Jun;217(6):1037-1041. doi: 10.1016/j.amjsurg.2019.01.014. Epub 2019 Jan 23. Am J Surg. 2019. PMID: 31029284 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical